Multiple Myeloma | Oncology Today with Dr Neil Love: Novel Agents Under Investigation in Multiple Myeloma

published 1 month ago by Dr Neil Love

Featuring a discussion of novel agents under investigation in multiple myeloma with Dr Peter Voorhees, including the following topics: Novel Agents in Relapsed/Refractory Multiple Myeloma (MM) — Peter Voorhees, MD (0:00) Mechanism of action of the novel peptide-drug conjugate melflufen; spectrum of treatment-related adverse events (28:30) Activity and mechanism of action of novel cereblon E3 ligase modulators in patients with relapsed/refractory MM (33:37) CME information and select publications

more episodes from Research To Practice | Oncology Videos